Reports: Legislative

October 05, 2016
SCR 11 of the 2016 Regular Legislative Session requires the Louisiana Department of Health (LDH) to evaluate and report on access to vital records at public health units.
August 10, 2016
ACT 158 of the 2015 Regular Legislative Session - The charge of ACT 158 of the 2015 Regular Session was to provide transparency relative to Medicaid managed care programs. ACT 158 amended the previous requirements for a managed care transparency report initiated by ACT 212 of the 2013 Regular Legislative Session.
July 22, 2016
In response to the reporting requirements set forth in House Concurrent Resolution 25 of the 2016 Regular Session, the Louisiana Department of Health (LDH) submits the attached report to the Legislature, the Commissioner of Administration and the Task Force on Structural Changes in Budget and Tax Policy, which outlines the department’s efficient operations for FY 16-17.
July 05, 2016
SCR 17 of the 2015 Regular Legislative Session directed the Louisiana Department of Health (LDH) to evaluate and report on the health benefits and costs of adding Krabbe disease to the current list of mandatory newborn screenings to be performed when it is recommended by the United States Department of Health and Human Services Discretionary Advisory Committee on Heritable Disorders in Newborns and Children, the American College of Medical Genetics, and the Louisiana Newborn Screening Advisory Committee.
July 01, 2016
The Louisiana Department of Health Strategic Plan and Process Documentation
June 06, 2016
The charge of Act 158 of the 2015 Regular Legislative Session was to provide transparency relative to Medicaid managed care programs. Within the Office of Behavioral Health (OBH), this involves the Louisiana Behavioral Health Partnership (LBHP) and its included Coordinated System of Care (CSoC).
April 29, 2016
The Louisiana Department of Health and Hospitals submits the attached report in response to SCR 3 of the 2016 Regular Legislative Session regarding the health benefits and healthcare costs associated with adding Adrenoleukodystrophy (ALD) to the newborn screening panel.
March 15, 2016
SB 689 of the 2004 Regular Session and HB 369 of the 2005 Regular Session required DHH to provide an annual written report to the governor and to the legislature regarding the cost of administering the preferred drug list, including the cost of administering the prior authorization function, the costs of development and maintenance of the preferred drug list and aggregate funds returned to the federal government related to pharmaceutical rebates, and an analysis of the utilization trends for medical services provided by the state and any correlation to the preferred drug list.
March 01, 2016
House Resolution 197 and Senate Resolution 191, both of the 2015 Regular Legislative Session, urges the Louisiana Department of Health and Hospitals (DHH) to develop a study committee on family caregiving and long-term care services.
February 12, 2016
The Division of Administration, the Department of Health and Hospitals, and the Board of Supervisors of Louisiana State University, submits the attached response to HCR 139 of the 2013 Regular Session of the Louisiana Legislature regarding the operation and management of state hospitals by private entities to the House and Senate Committees on Health and Welfare and to the Joint Legislative Committee on the Budget.